1
Interventional Therapy Sequential With the Fourth-generation CAR-T Targeting Nectin4/FAP for Malignant Solid Tumors
Condition(s):Nectin4-positive Advanced Malignant Solid TumorLast Updated:November 18, 2020Recruiting
Solid Tumor: 13515 Clinical Trials, Page 1 of 1352
Hide Studies Not Open or Pending
2
A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid Tumours
Condition(s):Advanced Solid TumoursLast Updated:June 13, 2022Active, not recruiting
3
Advanced Refractory Solid Tumors With TP53 Mutations Register Study
Condition(s):Solid Tumor, AdultLast Updated:August 20, 2019Unknown status
4
Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors
Condition(s):Solid TumorLast Updated:February 25, 2022Recruiting
5
Genetic Investigation of Solid Tumors Cohort
Condition(s):Prostate Cancer; Colon CancerLast Updated:June 12, 2014Completed
6
Molecular Characterization of Genetic Alterations in Pediatric Solid Tumors
Condition(s):Pediatric Solid TumorsLast Updated:February 26, 2021Recruiting
7
Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors
Condition(s):Osteosarcoma; Ewing Sarcoma; Rhabdomyosarcoma; Relapsed Pediatric Solid Tumor; Refractory Pediatric Solid Tumor; Melanoma; Hepatoblastoma; Hepatocellular Carcinoma; Neuroblastoma; Wilms TumorLast Updated:March 31, 2022Recruiting
8
TCR-T Cell for Immunotherapy of Lung Cancer and Other Solid Tumors
Condition(s):Nonsmall Cell Lung Cancer; Solid Tumor, AdultLast Updated:September 24, 2021Recruiting
9
Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors
Condition(s):Advanced Solid TumorLast Updated:February 18, 2022Recruiting
10
Anlotinib in Advanced Solid Tumors With FGFR Alteration
Condition(s):Advanced Solid TumorLast Updated:April 29, 2019Recruiting